STOCK TITAN

Confluent, Inc. Form 4 Filings

CFLT NASDAQ

Every Form 4 that Confluent, Inc. (CFLT) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow CFLT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CFLT filings page.

Rhea-AI Summary

Confluent, Inc.’s chief executive officer, Edward Jay Kreps, reported a series of dispositions tied to the company’s merger with International Business Machines Corporation (IBM). Multiple blocks of Class B common stock, including 14,017,500 shares, were disposed of to the issuer in connection with the closing.

Under the merger terms, each share of Confluent Class A and Class B common stock was canceled and converted into the right to receive $31.00 per share in cash, subject to withholding taxes. Outstanding stock options and restricted stock units were also canceled; options were exchanged for cash based on the spread to the $31.00 price, while outstanding RSUs were assumed by IBM and converted into 37,778 IBM restricted stock units. Following these transactions, the filing shows no remaining Confluent equity or derivative holdings for Kreps.

Rhea-AI Summary

Confluent, Inc. Chief Accounting Officer Phan Kong reported the cancellation of his Confluent equity in connection with the company’s cash merger with IBM. Each share of Confluent Class A common stock was converted into the right to receive $31.00 in cash, subject to taxes.

He disposed of 149,758 shares of Class A common stock and 96,078 restricted stock units, all in issuer transactions tied to the merger. Fully vested stock options for 11,103 and 21,623 shares were also canceled for cash equal to their intrinsic value based on the $31.00 per‑share price, leaving no remaining Confluent equity holdings reported after these transactions.

Rhea-AI Summary

Sivaram Rohan reported disposition transactions in this Form 4 filing.

Confluent, Inc. completed its cash merger with IBM, triggering a full cleanup of CFO Rohan Sivaram’s Confluent equity. Each share of Confluent Class A common stock was canceled and converted into the right to receive $31.00 per share in cash, subject to taxes. All reported Confluent shares and options show zero remaining after these transactions.

Pursuant to the merger terms, the CFO’s restricted stock units were assumed by IBM and converted into restricted stock units for 39,985 shares of IBM common stock. A fully vested stock option covering 91,813 Confluent shares at an exercise price of $7.34 per share was canceled in exchange for cash equal to its intrinsic value, calculated using the $31.00 per-share merger price.

Rhea-AI Summary

Confluent, Inc. director Neha Narkhede reported the cash-out of her equity in connection with a merger. Pursuant to a Merger Agreement among Confluent, International Business Machines Corporation and Corvo Merger Sub, each share of Confluent Class A and Class B Common Stock was canceled and converted into the right to receive $31.00 per share in cash, subject to withholding taxes. Her RSUs were canceled for a cash amount equal to $31.00 multiplied by the number of underlying Class A shares, and her vested stock options were canceled for cash equal to the number of option shares times the excess of the $31.00 per share price over the option exercise price. Following these dispositions to the issuer, she reports no remaining shares or options in this filing.

Rhea-AI Summary

Confluent, Inc. director Michelangelo Volpi reported the disposition of his Class A Common Stock in connection with the company’s cash merger. On March 17, 2026, a total of 235,041 directly held shares and 155,512 shares held through the Volpi-Cupal Family Trust were canceled under the merger terms. Each share of Class A Common Stock was converted into the right to receive $31.00 per share in cash, without interest and subject to applicable withholding taxes. Following these issuer dispositions, the filing shows no remaining Class A Common Stock reported for Volpi.

Rhea-AI Summary

Confluent, Inc. director Eric Vishria reported disposing of his equity in connection with the company’s merger with International Business Machines Corporation. On March 17, 2026, his Class A Common Stock, including 12,559 shares held directly and shares held by entities he controls, was canceled and converted into the right to receive $31.00 per share in cash, without interest and subject to withholding taxes. Restricted Stock Units covering 8,302 shares were also canceled and exchanged for cash equal to $31.00 multiplied by the number of underlying shares. Following these transactions, the filing shows no remaining reported holdings.

Rhea-AI Summary

Confluent, Inc. director Gregory George Schott reported dispositions tied to the cash acquisition of the company by International Business Machines Corporation. Under the merger, each Class A share was canceled and converted into the right to receive $31.00 in cash, before taxes.

Schott’s Class A shares, including those held directly and by trust, were returned to the issuer for cash. His restricted stock units were canceled for a cash amount based on the $31.00 per-share price, and a fully vested stock option over 450,944 shares at a $4.71 exercise price was similarly canceled for cash. Following these transactions, the filing shows no remaining shares or options.

Rhea-AI Summary

Confluent, Inc. director Matthew Craig Miller, through an estate planning vehicle, reported a disposition of 9,886 shares of Class A Common Stock back to the company. Under a previously signed merger agreement, each share was canceled and converted into the right to receive $31.00 in cash, before any applicable taxes. Following this transaction, the filing shows zero indirect shares remaining for this estate planning vehicle.

Rhea-AI Summary

Confluent, Inc. director Alyssa Henry reported that her equity awards were cashed out in connection with the company’s merger with International Business Machines Corporation. Under the merger terms, each share of Class A Common Stock was canceled and converted into the right to receive $31.00 in cash per share, subject to taxes.

Henry disposed of 20,247 shares of Class A Common Stock and 8,302 Restricted Stock Units, each converted into the cash merger consideration. A fully vested stock option covering 187,500 shares with a $19.95 exercise price was also canceled in exchange for cash equal to the per-share merger price minus the exercise price, multiplied by the option shares.

Rhea-AI Summary

Confluent, Inc. director Jonathan Chadwick disposed of his equity in connection with the company’s merger with International Business Machines Corporation. A total of 485,938 shares of Class A Common Stock were canceled and converted into the right to receive $31.00 per share in cash, subject to withholding taxes. An additional 8,302 Restricted Stock Units were canceled in exchange for cash equal to $31.00 multiplied by the number of underlying shares. Following these transactions, Chadwick reported no remaining holdings of these securities.

Rhea-AI Summary

Confluent, Inc. director Lara Caimi reported the cancellation and cash-out of her equity in connection with a merger involving International Business Machines Corporation. On March 17, 2026, 186,107 shares of Class B Common Stock and 3,222 shares of Class A Common Stock were disposed of in issuer transactions and converted into the right to receive $31.00 per share in cash, without interest and subject to withholding taxes. In addition, 8,302 Restricted Stock Units were canceled for a cash payment equal to $31.00 multiplied by the number of underlying Class A shares. Following these transactions, Caimi held no remaining Confluent shares or RSUs.

Rhea-AI Summary

Confluent, Inc. Chief Financial Officer Rohan Sivaram sold 29,996 shares of Class A Common Stock in an open-market transaction at an average price of $30.67 per share. The sale took place on March 12, 2026, under a pre-arranged Rule 10b5-1 trading plan dated December 11, 2025.

Following this transaction, Sivaram directly holds 531,971 shares of Confluent stock, which includes 1 share purchased under the company’s 2021 Employee Stock Purchase Plan on March 12, 2026. The sale represents only a small portion of his overall reported holdings.

Rhea-AI Summary

Confluent, Inc. Chief Accounting Officer Phan Kong exercised stock options to acquire additional Class A common shares. On March 5, 2026, he exercised options covering 6,377 shares at $15.68 per share and 21,231 shares at $4.71 per share, totaling 27,608 newly acquired shares of Class A common stock. Following these exercises, his direct Class A common stock holdings increased to 245,836 shares. The related stock options were reported as fully vested.

Rhea-AI Summary

Confluent, Inc. reported an insider transaction by its Chief Financial Officer, Rohan Sivaram. On February 20, 2026, he executed an open-market sale of 21,503 shares of Class A common stock at $30.70 per share. According to the disclosure, these shares were sold to cover the tax obligation arising from the vesting of previously reported restricted stock units. After this transaction, he directly held 561,966 shares, which includes 1,398 shares acquired through Confluent’s employee stock purchase plan on February 13, 2026.

Rhea-AI Summary

Confluent, Inc. Chief Revenue Officer Mac Ban Ryan Norris reported open-market sales of a total of 31,273 shares of Class A common stock. He sold 11,517 shares on February 20 at $30.70 per share and 19,756 shares on February 24 at $30.66 per share. After these trades, he held 358,890 shares directly. Footnotes state the reported shares were sold to cover tax obligations from vested restricted stock units, were executed under a Rule 10b5-1 trading plan dated August 22, 2025, and occurred at prices ranging from $30.63 to $30.72.

Rhea-AI Summary

Confluent, Inc. Chief Accounting Officer Phan Kong reported an open-market sale of Class A common stock mainly to cover taxes tied to a restricted stock unit vesting. The transaction involved 2,277 shares at a weighted-average price of $30.70 per share. After this sale, Kong directly owns 218,228 shares of Confluent Class A common stock, indicating the sale was small relative to his remaining stake.

Rhea-AI Summary

Confluent, Inc. CEO Edward Jay Kreps reported a combination of share conversions and sales. He converted 232,500 shares of Class B Common Stock into 232,500 shares of Class A Common Stock through a derivative security conversion at a stated price of $0.00 per share, bringing his direct Class B holdings to 14,017,500 shares.

On the same date, he sold 270,207 shares of Class A Common Stock in open-market transactions at a price of $30.70 per share, executed under a Rule 10b5-1 trading plan adopted on August 15, 2024. After these sales, his direct Class A holdings were 301,660 shares. Additional Class B shares are held indirectly through family trusts.

Rhea-AI Summary

Confluent, Inc.’s Chief Revenue Officer, Ryan Mac Ban Norris, reported open-market sales of Class A common stock under a pre-arranged 10b5-1 trading plan dated August 22, 2025. He sold 1,655 shares at $30.54 on February 13, 2026 and 2,113 shares at $30.61 on February 18, 2026, totaling 3,768 shares.

After these transactions, he directly owned 390,163 shares of Confluent Class A common stock. This amount includes 1,398 shares acquired through the company’s employee stock purchase plan on February 13, 2026, indicating he retains a substantial equity position following the scheduled sales.

Rhea-AI Summary

Confluent, Inc. director Michelangelo Volpi reported that the Volpi-Cupal Family Trust, with which he is associated as trustee, sold 25,000 shares of Class A common stock in an open‑market transaction. The shares were sold at an average price of about $30.59 per share under a Rule 10b5-1 trading plan dated June 13, 2025.

According to the disclosure, the sale prices ranged from $30.535 to $30.63 per share. After this transaction, the trust held 155,512 shares of Class A common stock, and Volpi also reported 235,041 shares held directly. The filing notes that he disclaims beneficial ownership of the trust’s shares except to the extent of any pecuniary interest.

Rhea-AI Summary

Confluent, Inc. director Neha Narkhede reported a combination of option exercises, share conversions, and an open-market sale. She exercised stock options for 80,000 shares, which led to the conversion of 80,000 shares of Class B Common Stock into 80,000 shares of Class A Common Stock. She then sold 80,000 Class A shares at a price of $30.59 per share pursuant to a pre-established Rule 10b5-1 trading plan adopted on June 10, 2025. After these transactions, she held 28,549 shares of Class A Common Stock directly and 1,787 shares of Class A Common Stock indirectly through a trust, while retaining a substantial Class B stake and remaining option holdings.

Rhea-AI Summary

Confluent, Inc. director Eric Vishria, through entities he controls, reported an open-market sale of 61,905 shares of Class A common stock on February 13, 2026 at an average price of $30.57 per share under a pre-arranged 10b5-1 trading plan. After this indirect sale, entities he controls held 663,637 shares, and he also reported 20,861 shares held directly.

Rhea-AI Summary

Confluent, Inc.’s Chief Revenue Officer Mac Ban Ryan Norris received a grant of 59,854 Class A common stock restricted stock units on January 26, 2026. The units were granted at a price of $0 per share and vest quarterly through May 2027.

After this equity award, Norris beneficially owns 392,533 Class A shares in direct form. This filing reflects equity compensation rather than an open‑market purchase or sale.

Rhea-AI Summary

Confluent, Inc.'s chief financial officer reported a disposition of 6,667 shares of Class A common stock on 12/12/2025. The transaction, coded "G" and recorded at a price of $0 per share, left the officer with 582,071 shares beneficially owned on a direct basis. The report was filed by a single reporting person in their capacity as an officer of the company.

Rhea-AI Summary

Confluent, Inc.'s chief executive officer and director reported exercising stock options for Class B common stock, converting those shares into Class A common stock and then selling the resulting Class A shares. On 12/12/2025, he converted 506,000 shares of Class B into Class A and sold 506,000 Class A shares at prices ranging from $30.02 to $30.10. On 12/15/2025, he converted 232,500 shares of Class B into Class A and sold 232,500 Class A shares at prices between $30.05 and $30.14.

After these transactions, he directly owned 339,367 shares of Class A common stock. The filing also shows additional positions related to Class A common stock held indirectly through family trusts, including 149,984 shares in a 2018 revocable trust and 1,000,000-share positions in each of two 2019 irrevocable trusts. The 232,500-share sale on 12/15/2025 was made under a Rule 10b5-1 trading plan adopted on August 15, 2024.

Rhea-AI Summary

Confluent, Inc. director reported an insider transaction in company stock. On 12/10/2025, the director sold 1,074 shares of Class A common stock at $30 per share, and after this trade beneficial ownership stood at 11,524 shares held directly.

The sale was executed under a pre-arranged 10b5-1 Plan dated September 12, 2024, which is designed to meet the affirmative defense conditions of Rule 10b5-1(c) for trading according to a preset plan.

Rhea-AI Summary

Confluent, Inc. director reported insider transactions in Class A common stock. On 12/10/2025, entities controlled by the director sold 15,476 shares at $30 per share under a Rule 10b5-1 trading plan adopted on December 13, 2024, leaving 1,061,542 shares indirectly owned.

On 12/12/2025, those entities disposed of another 336,000 shares as a gift at $0, reducing indirect holdings to 725,542 shares. The director also holds 20,861 shares directly.

Rhea-AI Summary

Confluent, Inc. director reported equity transactions on December 10, 2025. The director exercised stock options to buy 23,100 shares of Class B common stock at $2.24 per share, which converted into an equal number of Class A shares. The director then sold 23,100 Class A shares at prices ranging from $30.00 to $30.02 under a Rule 10b5-1 trading plan adopted June 10, 2025. After these trades, the director held 28,549 Class A shares directly and 1,787 Class A shares indirectly through a trust.

Rhea-AI Summary

A Confluent, Inc. director reported option exercises, share conversions and a planned stock sale. On 12/10/2025, the director exercised stock options for 62,500 shares of Class B Common Stock at $19.95 per share, which are convertible into Class A Common Stock on a one-for-one basis.

On the same date, 62,500 shares of Class A Common Stock were acquired through conversion and 62,500 Class A shares were sold under a Rule 10b5-1 trading plan dated March 13, 2025 at prices ranging from $30.00 to $30.005 per share. After these transactions, the director directly owned 28,549 shares of Class A Common Stock and 187,500 derivative securities.

Rhea-AI Summary

Confluent, Inc.'s chief financial officer reported a planned stock sale under a Rule 10b5-1 trading plan. On 12/01/2025, the executive sold 8,000 shares of Class A common stock at prices ranging from $21.71 to $22.63 as part of a pre-arranged plan dated September 12, 2024. After this transaction, the officer beneficially owns 591,738 shares of Confluent Class A common stock.

Rhea-AI Summary

Confluent, Inc. (CFLT) reported an insider stock transaction by its Chief Financial Officer. On 11/20/2025, the CFO sold 25,858 shares of Class A common stock at $22.51 per share. After this transaction, the executive beneficially owns 599,738 shares directly.

The company notes that the shares sold represent stock disposed of to cover tax obligations arising from the vesting of previously granted restricted stock units. This means the sale was tied to equity compensation rather than an open‑market reduction of the executive’s core holdings.

Rhea-AI Summary

Confluent, Inc. (CFLT) filed a Form 4 reporting an insider share sale tied to tax withholding. The company’s Chief Accounting Officer reported selling 2,640 shares of Class A common stock on 11/20/2025 at a price of $22.51 per share. According to the filing, these shares were sold to cover the tax obligation arising from the vesting of previously granted restricted stock units. After this transaction, the reporting person beneficially owns 228,891 shares of Confluent Class A common stock, held directly.

Rhea-AI Summary

Confluent, Inc. (CFLT) Chief Revenue Officer reports tax-related share sale. On 11/20/2025, the officer sold 15,062 shares of Class A common stock at $22.51 per share. The company notes this sale was made to cover tax obligations arising from the vesting of previously granted restricted stock units. After this transaction, the officer directly holds 381,064 shares of Confluent Class A common stock.

Rhea-AI Summary

Confluent, Inc. (CFLT) disclosed that its chief executive officer, who is also a director, reported open-market sales of Class A common stock. On 11/20/2025, the insider sold 23,787 shares at an average price of $21.83 and 13,920 shares at an average price of $22.84, and reported beneficial ownership of 339,367 Class A shares after these transactions, all held directly. The filing notes that the sales were made under a Rule 10b5-1 trading plan adopted on August 15, 2024, with sale prices for each trade falling within specified ranges.

Rhea-AI Summary

Confluent, Inc. (CFLT) reported insider activity by its Chief Executive Officer and director on a Form 4 for 11/13/2025. The CEO converted 232,500 shares of Class B Common Stock into the same number of Class A Common Stock and then sold 232,500 Class A shares in an open market transaction at an average price of $23.53 per share under a pre-arranged Rule 10b5-1 trading plan adopted on August 15, 2024. After these transactions, the CEO directly owned 377,074 shares of Class A Common Stock and held 14,482,500 derivative securities in the form of Class B Common Stock, each convertible into one Class A share. Additional Class B holdings convertible into Class A shares are reported as indirectly owned through several family trusts.

Rhea-AI Summary

Confluent, Inc. (CFLT) reported an insider transaction. A company director exercised options, converted shares, and sold stock on 11/03/2025 under a pre-set Rule 10b5-1 plan.

The insider exercised 30,000 stock options at an exercise price of $2.24, received Class B shares, then converted 30,000 Class B into 30,000 Class A on a one-for-one basis. The insider then sold 30,000 Class A shares at an average price of $23.57, with trades ranging from $23.17 to $23.89.

Following these transactions, the insider held 28,549 Class A shares directly and 1,787 Class A shares indirectly via a trust. The option award referenced was fully vested.

Rhea-AI Summary

Confluent (CFLT) Form 4: The Chief Financial Officer sold 6,000 shares of Class A common stock on 10/29/2025 pursuant to a Rule 10b5-1 trading plan dated September 12, 2024. The filing notes sale prices ranged from $23.51 to $24.00, with a line-item price shown at $23.76 for the reported transaction. Following the sale, the reporting person beneficially owns 625,596 shares, held directly.

Rhea-AI Summary

Confluent (CFLT) insider transaction: A company officer (Chief Accounting Officer) reported selling 1,003 shares of Class A common stock on 10/29/2025 at $24 per share under a Rule 10b5-1 trading plan. Following the sale, the officer directly beneficially owns 231,531 shares. The filing indicates the transaction was executed pursuant to a pre-established plan dated September 12, 2024.

Rhea-AI Summary

Confluent, Inc. (CFLT) director reported an open-market sale of Class A common stock. On 10/29/2025, the reporting person sold 30,953 shares (transaction code S) pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2024.

The filing lists a reported price of $23.64, with actual sale prices ranging from $23.17 to $23.98. Following this transaction, the reporting person beneficially owns 1,092,494 shares indirectly and 20,861 shares directly. The indirect holdings are noted as being held by entities controlled by the reporting person.

Rhea-AI Summary

Confluent (CFLT) Form 4: On 10/29/2025, a director exercised 30,000 stock options at $2.24, converting Class B into Class A, and sold 30,000 Class A shares pursuant to a Rule 10b5-1 plan adopted on June 10, 2025. The sale occurred at prices ranging from $23.19 to $24.01. Following these transactions, the director directly held 28,549 Class A shares and indirectly held 1,787 shares via a trust.

Rhea-AI Summary

Phan Kong, Chief Accounting Officer of Confluent, Inc. (CFLT), reported an insider sale on 09/22/2025. The filing shows 4,544 shares of Class A common stock were sold at $19.87 per share to cover the tax obligation arising from the vesting of restricted stock units. After the sale, the reporting person beneficially owned 232,534 shares. The Form 4 was executed on behalf of the reporting person by an attorney-in-fact on 09/24/2025. No derivative transactions or other types of securities were reported in this filing.

Rhea-AI Summary

Confluent, Inc. insider filing shows Mac Ban Ryan Norris, the company's Chief Revenue Officer, reported a sale of 1,219 shares of Class A common stock on 09/22/2025 at a price of $19.87 per share. The filing states the sale was to cover the tax obligation arising from the vesting of previously granted restricted stock units. After the reported transaction, Mr. Norris beneficially owns 396,126 shares of Class A common stock, held directly. The Form 4 was signed on 09/24/2025.